Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
United Kingdom

Downing Ventures

Investment focus

Sectors

Enterprise
Deeptech
Healthtech
Fintech
Cybersecurity

Investment stages

Seed
Series A
Series B

Geographic focus

United Kingdom

Investment thesis

Venture capital division of Downing LLP (B Corp-certified UK investment manager with GBP 2.1B AUM). Invests through VCTs and EIS in early and growth-stage UK technology businesses.

Typical check size

€250k – €5M

Fund size: ~EUR 115M (within Downing LLP GBP 2.1B AUM)

Browse similar check sizes →

Portfolio highlights

Ayar Labs - optical I/O chiplets for semiconductors (unicorn)
Touchlight - enzymatic DNA manufacturing platform (unicorn)
Destiny Pharma - anti-infective treatments for drug-resistant bacteria (AIM-listed)

Contact

www.downingventures.com
United Kingdom

Research with AI

Learn more about Downing Ventures using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Downing Ventures and similar investors look for:

Enterprise pitch guideHealthtech pitch guideFintech pitch guide

More investors in United Kingdom

20VC21506 Degrees Capital83NorthView all in United Kingdom

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideFintech pitch deck by model
Fundraising in United Kingdom

Tips, programs, and cultural notes

More Enterprise investors

20VC2123VC468 CapitalView all Enterprise investors